Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial.
Valery S, Simon-Tillaux N, Devouassoux G, Bonniaud P, Beurnier A, Boudjemaa A, Chenivesse C, Bourdin A, Gauquelin L, Guillo S, Taillé C, Estellat C; RAMSES Study Group. Valery S, et al. J Allergy Clin Immunol. 2024 Oct;154(4):922-932. doi: 10.1016/j.jaci.2024.05.023. Epub 2024 Jun 6. J Allergy Clin Immunol. 2024. PMID: 38848878 Clinical Trial.
Venous thromboembolism and amyotrophic lateral sclerosis: the Venous Thrombo-Embolism and Sclerosis Lateral Amyotrophic study.
Barnabe A, Genestet S, Gut-Gobert C, Rivalain C, Noury JB, Goret M, Barnier A, De Moreuil C, Espinasse B, Le Mao R, Leroyer C, Couturaud F, Tromeur C. Barnabe A, et al. Among authors: leroyer c. Res Pract Thromb Haemost. 2023 Nov 30;8(1):102287. doi: 10.1016/j.rpth.2023.102287. eCollection 2024 Jan. Res Pract Thromb Haemost. 2023. PMID: 38371336 Free PMC article.
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
Rambaud G, Mai V, Motreff C, Sanchez O, Roy PM, Auffret Y, Le Mao R, Gagnadoux F, Paleiron N, Schmidt J, Pastre J, Nonent M, Tromeur C, Salaun PY, Mismetti P, Girard P, Lacut K, Lemarié CA, Meyer G, Leroyer C, Le Gal G, Bertoletti L, Couturaud F; “PEP” investigators. Rambaud G, et al. Among authors: leroyer c. Thromb Res. 2023 Nov;231:58-64. doi: 10.1016/j.thromres.2023.09.013. Epub 2023 Sep 28. Thromb Res. 2023. PMID: 37806116
Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.
Pereira S, Verhille J, Cailliau E, Bonniaud P, Devouassoux G, Fry S, Guilleminault L, Khayath N, Leroyer C, Chenivesse C, Bautin N. Pereira S, et al. Among authors: leroyer c. Clin Exp Allergy. 2023 Dec;53(12):1298-1301. doi: 10.1111/cea.14392. Epub 2023 Sep 13. Clin Exp Allergy. 2023. PMID: 37705326 No abstract available.
SQ HDM Sublingual Immunotherapy Tablet for the Treatment of HDM Allergic Rhinitis and Asthma Improves Subjective Sleepiness and Insomnia: An Exploratory Analysis of the Real-life CARIOCA Study.
Jaffuel D, Serrano E, Leroyer C, Chartier A, Demoly P. Jaffuel D, et al. Among authors: leroyer c. J Investig Allergol Clin Immunol. 2024 Oct 23;34(5):323-330. doi: 10.18176/jiaci.0934. Epub 2023 Sep 4. J Investig Allergol Clin Immunol. 2024. PMID: 37669078 Free article.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis.
Goualou M, Noumegni S, de Moreuil C, Le Guillou M, De Coninck G, Hoffmann C, Robin S, Morcel K, Le Moigne E, Tremouilhac C, Merviel P, Le Mao R, Leroyer C, Bouée S, Couturaud F, Tromeur C. Goualou M, et al. Among authors: leroyer c. Thromb Haemost. 2023 Mar;123(3):283-294. doi: 10.1055/s-0042-1760255. Epub 2022 Dec 31. Thromb Haemost. 2023. PMID: 36588288
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
Durier C, Ninove L, Lefebvre M, Radenne A, Desaint C, Ropers J, Bauer R, Lebbah S, Carette D, Lachatre M, Lecompte AS, Deplanque D, Botelho-Nevers E, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian J, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Priet S, Levier A, Molino D, Vieillard LV, Parfait B, Lelièvre JD, Tartour E, de Lamballerie X, Launay O; ANRS0002S CoviCompareP Group; AP-HP CoviCompareM Group; Biological resource centers; Laboratories; Trial coordination; Sponsor; Scientific Committee. Durier C, et al. Sci Rep. 2022 Nov 27;12(1):20373. doi: 10.1038/s41598-022-24409-w. Sci Rep. 2022. PMID: 36437298 Free PMC article.
180 results